Biotech Values

[DewDiligence]

>>The company is in solid-rock-excellent shape,but still investors are fleeing in an almost stampede pace.<<

I’m thoroughly accustomed to buying a stock on the way down. Most of my ultimate gains show losses at the outset. (It recently happened with OSIP, for instance.) What transpired today with TEVA is not even a slight worry as far as I’m concerned.

I was impressed by TEVA’s NY luncheon today. There may be only two or three companies in the entire world capable of capitalizing on generic biologics; TEVA is clearly one of them.

>> I am entiteled 18 posts,and this is my last.<<

Talk to you tomorrow. Regards, Dew